Opthea Secures A$10.8M R&D Tax Incentive
Ticker: OPTEY · Form: 6-K · Filed: Oct 6, 2025 · CIK: 1815620
Sentiment: bullish
Topics: grant, r&d, government-funding
TL;DR
Opthea just got A$10.8M from the Aussie gov't R&D tax credit - good for cash flow!
AI Summary
Opthea Limited announced on October 6, 2025, that it received A$10.8 million from the Australian Government's Research and Development (R&D) Tax Incentive program. This funding is intended to support Opthea's ongoing research and development activities for its novel therapies.
Why It Matters
This R&D tax incentive provides crucial non-dilutive funding, supporting Opthea's development of innovative therapies and potentially reducing the need for immediate equity financing.
Risk Assessment
Risk Level: low — The filing is a routine announcement of a government grant, which is generally positive and low-risk.
Key Numbers
- A$10.8 million — R&D Tax Incentive (Funding received from the Australian Government to support research and development.)
Key Players & Entities
- Opthea Limited (company) — Filing company
- A$10.8 million (dollar_amount) — R&D Tax Incentive received
- October 2025 (date) — Reporting period
- Australian Government (company) — Provider of R&D Tax Incentive
FAQ
What is the purpose of the A$10.8 million received by Opthea Limited?
The A$10.8 million was received from the Australian Government's Research and Development (R&D) Tax Incentive program to support Opthea's ongoing research and development activities for its novel therapies.
When was this R&D Tax Incentive funding announced?
The announcement was made on October 6, 2025, as part of a Form 6-K filing.
What type of company is Opthea Limited?
Opthea Limited is a company in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) sector, with SIC code 2836.
Where is Opthea Limited's principal executive office located?
Opthea Limited's principal executive office is located at Level 4, 650 Chapel Street, South Yarra, Victoria, 3141, Australia.
What form does Opthea Limited file annually?
Opthea Limited files its annual reports under cover of Form 20-F.
Filing Stats: 148 words · 1 min read · ~1 pages · Grade level 12.1 · Accepted 2025-10-06 06:01:03
Key Financial Figures
- $10.8 million — 99.1 Press Release - Opthea Received A$10.8 million R&D Tax Incentive SIGNATURES Pursua
Filing Documents
- opt_rd_tax_a10.8million.htm (6-K) — 27KB
- opt-ex99_1.htm (EX-99.1) — 19KB
- img260626642_0.jpg (GRAPHIC) — 151KB
- img260626642_1.jpg (GRAPHIC) — 151KB
- 0001193125-25-230839.txt ( ) — 464KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Jeremy Levin Name: Jeremy Levin Title: Executive Officer Date: 10/06/2025